ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,406Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 617

$536K Total Retail Price of All Prescriptions

Rank: 78 out of 617

447 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 447 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 447 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 9,688 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 477 429 1 2
OMEPRAZOLE 430 375 2 3
FUROSEMIDE 385 363 3 4
WARFARIN SODIUM 358 344 4 7
LEVOTHYROXINE SODIUM 333 285 5 1
METFORMIN HCL 267 232 6 9
POTASSIUM CHLORIDE 259 236 7 10
HYDROCODONE-ACETAMINOPHEN 256 182 S3 8 8
FENTANYL 218 173 S2 9 45
METOPROLOL TARTRATE 214 197 10 11
ALLOPURINOL 205 201 11 27
ENALAPRIL MALEATE 204 170 12 34
AMLODIPINE BESYLATE 174 154 13 6
POLYETHYLENE GLYCOL 3350 172 146 14 32
LISINOPRIL 167 163 15 5
PREDNISONE 162 159 16 31
GABAPENTIN 161 136 17 16
OXYCODONE-ACETAMINOPHEN 156 127 S2 18 93
TRAMADOL HCL 127 94 19 15
CIPROFLOXACIN HCL 124 117 20 60
METOPROLOL SUCCINATE 115 109 21 12
LANTUS SOLOSTAR 108 92 22 115
GLYBURIDE 104 100 R 23 84
IBUPROFEN 98 72 24 140
AZITHROMYCIN 97 83 25 70
CARVEDILOL 96 92 26 19
ATORVASTATIN CALCIUM 92 85 27 14
LOSARTAN POTASSIUM 88 79 28 22
LANTUS 88 81 28 39
SPIRONOLACTONE 88 72 28 42
BISOPROLOL FUMARATE 84 78 31 100
ADVAIR DISKUS 84 84 31 38
PAROXETINE HCL 83 82 33 62
PRAMIPEXOLE DIHYDROCHLORIDE 82 72 34 153
DOXAZOSIN MESYLATE 82 79 34 79
FINASTERIDE 77 77 36 104
ATENOLOL 76 76 37 17
CRESTOR 76 54 37 28
GLIPIZIDE 76 64 37 82
FLUOXETINE HCL 75 55 40 73
HYDROCHLOROTHIAZIDE 70 70 41 13
SERTRALINE HCL 69 69 42 20
TAMSULOSIN HCL 67 67 43 26
SYNTHROID 67 54 43 59
MORPHINE SULFATE 65 13 S2 45 249
CLOPIDOGREL 62 62 46 53
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 55 46 91
ZOLPIDEM TARTRATE 60 40 48 23
CELEBREX 60 34 48 63
ZETIA 58 58 50 77
PREMARIN 56 43 R 51 108
DIGOXIN 56 38 51 48
METOLAZONE 55 52 53 159
PLAVIX 52 52 54 86
CEPHALEXIN 51 48 55 68
NAPROXEN 51 34 55 101
FLUTICASONE PROPIONATE 51 47 55 36
MORPHINE SULFATE ER 50 31 S2 58 128
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.